Diagnostic value of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV.
C YanavichAntonio Guilherme PachecoS W CardosoE P NunesUsb ChavesG FreitasR SantosM MorataValdilea Gonçalves VelosoBeatriz Gilda Jegerhorn GrinsztejnHugo PerazzoPublished in: HIV medicine (2021)
Biomarkers for NAFLD had a good accuracy and those for fibrosis had high specificities and NPVs. These tests should be integrated to HIV care to detect NAFLD and to exclude advanced liver fibrosis.